RICHARD CARR: Open Payments
NPI 1144223108 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 11 payments from 5 companies in 2025. Trend: 2023 $44 · 2024 $37 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $327 |
| Axsome Therapeutics, Inc. | 2 | $141 |
| Gilead Sciences, Inc. | 1 | $26 |
| Braeburn Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: SUBLOCADE, Auvelity, BRIXADI, FANAPT.
Industry payments across LA — which companies pay providers there.
